TCTMD

03/16/2026

03/16/2026

Data are early, retrospective, and unlikely to influence guidelines, but interest among operators is growing, says Sameh Sayfo.

03/16/2026

Diastolic BP was higher years after giving birth for women who reported stress—but only if they’d had a complicated pregnancy.

03/16/2026

With the rise of AI, the regulatory and ethical sides of using the tool need to be addressed. TCTMD's Todd Neale sits down with Ami Bhatt to discuss building infrastructure and guardrails for AI and what clinicians can do to participate in the effort. https://www.tctmd.com/videos/on-record-regulatory-and-ethical-issues-around-ai.6390747591112

03/16/2026

Women had better self-care at 5 years with self-expanding valves, raising questions about lower gradients and stroke impacts.

03/13/2026

The study of LAAO cases provides physicians with evidence they can cite when requesting tools for additional protection.

03/13/2026

LDL targets return with stronger recommendations around CAC and Lp(a) screening and a focus on lifetime risk.

03/13/2026

AI is transforming the area of cardiology, but can the tool streamline clinical trials? TCTMD's Todd Neale sits down with Jonathan Cunningham to talk about how AI can help, from patient selection to event adjudication. Watch the latest On Record now: https://www.tctmd.com/videos/on-record-how-can-ai-streamline-clinical-trials.6390497752112

03/13/2026

Geography once drove disparity, but access now hinges on how effectively centers can employ modern donor-utilization tools.

03/12/2026

Listen to Ami Bhatt and Henri Justino discuss strategies to support right ventricular growth, PA/IVS, and more on this episode of Heart Valve Matters. https://www.tctmd.com/audio/pediatric-and-congenital-heart-disease-series-how-encourage-growth-hypoplastic-right-hearts

03/12/2026

On this episode of Heart Valve Matters, Ami Bhatt and John Carney talk about how in-vivo assessments can inform the development of devices for pediatric patients. Listen now: https://www.tctmd.com/audio/pediatric-and-congenital-heart-disease-series-vivo-assessment-novel-cardiac-valve-prostheses

03/12/2026

Both CV mortality and major bleeding were rarer when antiplatelets weren’t added, with no tradeoff in ischemic events.